胃癌中MXD基因的预后影响和治疗潜力
1Scientific Research Center, Beijing ChosenMed Clinical Laboratory Co., Ltd. Beijing, 100176, China.
Current medicinal chemistry
|May 12, 2025
概括
马克斯二分化 (MXD) 基因家族在胃癌 (GC) 中表达的变化,MXD3 的下调预示着不良预后和作为免疫治疗标的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 马克斯二分化 (MXD) 基因与各种癌症有关.
- 它们在胃癌 (GC) 中的特定作用,预后价值和免疫治疗潜力尚未完全理解.
研究的目的:
- 研究GC中MXD基因的表达模式,预后意义和潜在的治疗作用.
主要方法:
- 使用威尔科克森等级总和测试和t测试的差异基因表达分析.
- 通过cBioPortal进行基因改变分析.
- 与临床参数的相关性分析和使用R软件的生存分析.
- 使用pROC包的诊断潜力的评估.
- 使用GSVA包的调控网络和免疫细胞透分析.
- 通过GSCA进行药物敏感性分析.
- 使用定量实时PCR (qRT-PCR) 验证.
主要成果:
- 在GC中,MXD1是上调的,而MXD3和MXD4是下调的.
- MXD3表达与T阶段和年龄相关;MXD4具有组织学等级.
- 低MXD3表达表明预后不佳,是独立的预后因素.
- MXD3显示出诊断的准确性 (AUC=0.884).
- MXDs通过免疫细胞,内细胞,细胞循环和细胞亡来影响GC.
- 表达与免疫透和药物敏感性相关.
结论:
- MXD基因家族具有潜在的潜力,作为GC中预后不佳的新生物标志物.
- MXD基因可以作为未来胃癌免疫疗法的点.
相关概念视频
Abnormal Proliferation
4.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K


